The role of the T-cell mediated immune response to Cytomegalovirus infection in intrauterine transmission

IntroductionPrognostic markers for fetal transmission of Cytomegalovirus (CMV) infection during pregnancy are poorly understood. Maternal CMV-specific T-cell responses may help prevent fetal transmission and thus, we set out to assess whether this may be the case in pregnant women who develop a prim...

Descripción completa

Detalles Bibliográficos
Autores: Soriano Ramos, María, Esquivel De la Fuente, Estrella, Albert Vicent, Eliseo, Calle Fernández-Miranda, María de la, Baquero Artigao, Fernando, Domínguez Rodríguez, Sara, Cabanes, María, Gómez Montes, Enery, Tagarro García, Alfredo, CYTRIC Study Group, Et al.
Tipo de recurso: artículo
Fecha de publicación:2023
País:España
Institución:Universidad Europea (UEM)
Repositorio:ABACUS. Repositorio de Producción Científica
Idioma:español
OAI Identifier:oai:abacus.universidadeuropea.com:11268/12654
Acceso en línea:http://hdl.handle.net/11268/12654
Access Level:acceso abierto
Palabra clave:Infecciones por Citomegalovirus
Transmisión Vertical de Enfermedad Infecciosa
Enfermedad transmisible
Embarazo
Descripción
Sumario:IntroductionPrognostic markers for fetal transmission of Cytomegalovirus (CMV) infection during pregnancy are poorly understood. Maternal CMV-specific T-cell responses may help prevent fetal transmission and thus, we set out to assess whether this may be the case in pregnant women who develop a primary CMV infection. MethodsA multicenter prospective study was carried out at 8 hospitals in Spain, from January 2017 to April 2020. Blood samples were collected from pregnant women at the time the primary CMV infection was diagnosed to assess the T-cell response. Quantitative analysis of interferon producing specific CMV-CD8(+)/CD4(+) cells was performed by intracellular cytokine flow cytometry. ResultsIn this study, 135 pregnant women with a suspected CMV infection were evaluated, 60 of whom had a primary CMV infection and samples available. Of these, 24 mothers transmitted the infection to the fetus and 36 did not. No association was found between the presence of specific CD4 or CD8 responses against CMV at the time maternal infection was diagnosed and the risk of fetal transmission. There was no transmission among women with an undetectable CMV viral load in blood at diagnosis. ConclusionsIn this cohort of pregnant women with a primary CMV infection, no association was found between the presence of a CMV T-cell response at the time of maternal infection and the risk of intrauterine transmission. A detectable CMV viral load in the maternal blood at diagnosis of the primary maternal infection may represent a relevant biomarker associated with fetal transmission.